Of the human organs, few have been subjected to the implementation of new techniques improving diagnostic efficacy to the extent that the female breast has. It all started with the introduction of mammography decades ago, followed by ultrasonography, different nuclear medicine techniques, and then magnetic resonance tomography. Even computed tomography has played a role in this succession of different modalities. Light in different forms has also been used in the investigation of breast tumors.
Currently under development are several methods based on the detection of electrophysiological properties. Whereas one of these methods is founded on differences in the electrical potential at skin level caused by neoplastic activity, others are based on measurements of the conductivity and capacitance of different tissues using multiple frequencies of alternating electric current.
In this issue of Acta Radiologica, Botond K. Szabó and co-workers at Karolinska Institutet present their experience with the first commercial product using impedance technology (3). Inhomogeneities in impedance maps have been shown to be correlated to breast malignancies. Although it was as long ago as 1926 that capacitance of tumor tissue was first shown to be different from normal tissue, commercial systems have not been available until recent years. In 1988, however, Dr. J. Jossinet from Lyon, France, described a system whereby data were collected from 16 electrodes around a breast (1) . The electrodes were actuated by pneumatic jacks and could be used on breasts between 7 and 17 cm in diameter. Jossinet has since expanded impedance techniques into other organ systems and in April this year he published an article about impedance changes in liver tissue (2) .
As with most new techniques, conflicting results have been reported. It is one thing to develop and implement new techniques and modalities, but quite another to evaluate them appropriately in a scientific way, as done in an evidence-based medicine system. Szabó and co-workers' conclusion that ''the theory behind electrical impedance is promising … but the role of targeted electrical impedance imaging is not justified by the results of this study'' is sound knowledge and shows that scientific studies using the proper methodology are important and that it is necessary to evaluate new techniques/modalities before they are adopted for widespread use in the routine workup of large groups of patients.
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